Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Enovix’s SEC disclosures can feel like navigating a lab manual. The company’s silicon-lithium battery platform, BreakFlow safety layer, and orthogonal cell architecture introduce technical details that stretch a single 10-K well past 250 pages. If you are searching for “Enovix SEC filings explained simply” or wondering where the capital for its new manufacturing lines is coming from, you are not alone.
Stock Titan bridges that gap. Our AI-powered summaries extract the numbers and narratives that matter—from Form 4 insider transactions in real time to each Enovix quarterly earnings report 10-Q filing. Type a natural question such as “understanding Enovix SEC documents with AI” and instantly see R&D spend trends, factory yield updates, and customer concentration data. We monitor every Enovix 8-K material events explained notice, flagging supply-chain shifts the moment they hit EDGAR, and track Enovix executive stock transactions Form 4 so you can spot buying or selling before the market digests it.
Whether you need an Enovix annual report 10-K simplified to grasp long-term production targets, an Enovix proxy statement executive compensation breakdown, or an Enovix earnings report filing analysis that highlights gross-margin progress, our platform delivers. You’ll also find a concise timeline of Enovix insider trading Form 4 transactions, interactive charts comparing quarter-over-quarter CapEx, and alert tools for “Enovix Form 4 insider transactions real-time.” Save time, understand the technology risks, and make informed decisions—without diving into every footnote.
Enovix Corp (ENVX) reported an insider equity transaction by its Chief Accounting Officer, Kristina Truong. On November 21, 2025, she received 3,833 shares of common stock through a fully vested restricted stock unit (RSU) award, serving as her bonus for the quarter ended September 28, 2025. Each RSU converts into one share of Enovix common stock.
To cover tax withholding related to this RSU award, 2,026 shares of common stock were withheld and disposed of at a price of $7.47 per share. After these transactions, Truong beneficially owned 200,309 shares of Enovix common stock, including shares issuable from outstanding RSUs and vested performance RSUs scheduled for release in March 2026 and March 2027.
Enovix Corporation (ENVX) reported insider equity activity for its Chief Legal Officer, Arthi Chakravarthy. On November 21, 2025, she received 4,960 shares of common stock at a price of $0, issued upon the receipt of fully vested restricted stock units (RSUs) earned as bonus for the quarter ended September 28, 2025, with each RSU equal to one share.
To cover tax withholding on RSU vesting, 2,622 shares were withheld on November 21, 2025 at $7.47 per share and 2,217 shares were withheld on November 24, 2025 at $7.58 per share. Following these transactions, Chakravarthy beneficially owned 424,156 shares, including 303,276 shares issuable from RSUs and 20,786 vested performance RSUs scheduled for releases in March 2026 and March 2027.
Enovix Corporation (ENVX) Chief Operating Officer Ajay Marathe reported equity award activity in company stock. On November 21, 2025, he received 6,035 shares of common stock at $0, issued upon the vesting of restricted stock units that represented his bonus for the quarter ended September 28, 2025.
On the same date, 3,190 shares were withheld at a price of $7.47 to cover tax obligations tied to the RSU vesting. After these transactions, Marathe beneficially owned 989,363 shares of Enovix common stock, including large amounts issuable from previously granted RSUs and vested performance RSUs scheduled for release in 2026 and 2027.
Enovix Corp (ENVX) reported a routine insider equity transaction by its Chief Financial Officer. On November 21, 2025, the reporting person received 5,729 shares of common stock through a fully vested restricted stock unit (RSU) award that served as a bonus for the quarter ended September 28, 2025, at a stated price of $0 per share. On the same date, 3,028 shares of common stock were withheld at $7.47 per share to cover tax obligations related to this RSU vesting. After these transactions, the reporting person beneficially owned 753,690 shares of Enovix common stock, including 748,752 shares issuable upon settlement of previously granted RSUs.
Enovix Corporation (ENVX) reported insider equity activity by its President and CEO, who is also a director. On November 21, 2025, the executive received 9,427 shares of common stock at $0, issued upon the vesting of restricted stock units (RSUs) that represent bonus awards for the quarter ended September 28, 2025. On the same date, 4,983 shares were withheld at a price of $7.47 to cover tax obligations tied to this RSU vesting.
Following these transactions, the executive beneficially owned 2,298,829 shares of Enovix common stock on a direct basis. This total includes 1,674,293 shares underlying RSUs and 95,551 vested performance RSUs (PRSUs), with half of the PRSUs scheduled for release on March 2, 2026 and the remainder on March 1, 2027. Each RSU or PRSU represents the right to receive one share of common stock.
Enovix Corporation (ENVX) reported an insider stock transaction by its President, CEO and Director, Raj Talluri. On November 20, 2025, he donated 925 shares of Enovix common stock to two charitable organizations at a reported price of $0, reflecting a gift rather than a sale. After this donation, he beneficially owned 2,294,385 shares of Enovix common stock. This total includes 1,674,293 shares issuable upon settlement of restricted stock units (RSUs) and 95,551 vested performance RSUs. For the performance RSUs, 50% are scheduled to be released on March 2, 2026 and the remaining 50% on March 1, 2027, with each PRSU representing the right to receive one share upon settlement.
Enovix Corporation (ENVX) president and CEO Raj Talluri, who also serves as a director, reported an automatic share withholding related to equity compensation. On November 18, 2025, 17,617 shares of Enovix common stock were withheld at a price of $7.50 per share to cover tax obligations triggered by the vesting of restricted stock units (RSUs). These are not open-market sales but shares retained by the company for taxes.
Following this transaction, Talluri beneficially owns 2,295,310 Enovix shares in total. This amount includes 1,674,293 shares issuable upon settlement of RSUs and 95,551 shares of vested performance RSUs (PRSUs), with half of the PRSUs scheduled to be released on March 2, 2026 and the remaining half on March 1, 2027. Each RSU and PRSU represents a right to receive one share of Enovix common stock.
Enovix Corporation’s Chief Operating Officer, Ajay Marathe, reported an automatic share withholding related to equity compensation. On November 14, 2025, 7,338 shares of Enovix common stock were withheld at $8.03 per share to cover tax obligations arising from the vesting of restricted stock units (RSUs). After this transaction, Marathe beneficially owned 986,518 shares, including 743,818 shares tied to unvested RSUs and 33,170 vested performance RSUs (PRSUs). Half of these PRSUs are scheduled for release on March 2, 2026, with the remaining half on March 1, 2027, each representing a right to receive one share upon settlement.
Enovix Corp (ENVX) reported an insider equity transaction by its Chief Accounting Officer, Kristina Truong. On November 13, 2025, 1,013 shares of common stock were withheld at a price of $8.08 to cover tax obligations related to the vesting of restricted stock units (RSUs). After this transaction, the reporting person beneficially owned 198,502 shares of common stock.
This total includes 155,474 shares issuable upon vesting and settlement of RSUs and 4,978 vested performance RSUs (PRSUs). For these PRSUs, 50% of the shares are scheduled to be released on March 2, 2026 and the remaining 50% on March 1, 2027, with each RSU or PRSU representing the right to receive one share of Enovix common stock.
Enovix (ENVX) reported an insider Form 4 for its Chief Accounting Officer. On November 10, 2025, 252 shares of common stock were withheld at $9.28 to satisfy taxes upon RSU vesting (code F, a non‑open‑market transaction). Following this, the officer beneficially owned 199,515 shares.
This ownership includes 157,389 shares issuable upon RSU settlement and 4,978 vested PRSUs, with 50% scheduled for release on March 2, 2026 and the remaining 50% on March 1, 2027. It also reflects 2,033 shares acquired under the 2021 ESPP on November 7, 2025.
FAQ
What is the current stock price of Enovix Corporation (ENVX)?
What is the market cap of Enovix Corporation (ENVX)?
